secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001104659-23-024791
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical Q4 revenue $1.58B (+1.4%), EPS $0.22; FY22 revenue $6.33B, EPS $1.23; declares $0.125 dividend
--------------------------------------------------------------------------------

- Q4 revenue $1,581.5M (+1.4% YoY); net income $37.7M (down 43%); EPS $0.22 vs $0.37.
- FY22 revenue $6,333.5M (+2.1%); net income $198.0M (down 60%); EPS $1.23 vs $2.98.
- Critical illness recovery hospital Q4 Adj EBITDA +80.5% to $44.3M; rehab hospital +42.5% to $56.0M.
- Board declared $0.125/share cash dividend payable March 15, 2023 to holders of record March 3, 2023.
- 2023 revenue guidance $6.5B-$6.7B; no Adj EBITDA/EPS guidance due to labor uncertainties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465923024791/0001104659-23-024791-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465923024791/tm237521d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-024791

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer